Search Results

There are 209 results for: content related to: CD22 monoclonal antibody therapies in relapsed/refractory acute lymphoblastic leukemia

  1. You have free access to this content
    Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia

    Cancer

    Volume 119, Issue 15, 1 August 2013, Pages: 2728–2736, Hagop Kantarjian, Deborah Thomas, Jeffrey Jorgensen, Partow Kebriaei, Elias Jabbour, Michael Rytting, Sergernne York, Farhad Ravandi, Rebecca Garris, Monica Kwari, Stefan Faderl, Jorge Cortes, Richard Champlin and Susan O'Brien

    Version of Record online : 30 APR 2013, DOI: 10.1002/cncr.28136

  2. You have free access to this content
    Prognostic factors for outcome in patients with refractory and relapsed acute lymphocytic leukemia treated with inotuzumab ozogamicin, a CD22 monoclonal antibody

    American Journal of Hematology

    Volume 90, Issue 3, March 2015, Pages: 193–196, Elias Jabbour, Susan O'Brien, Xuelin Huang, Deborah Thomas, Michael Rytting, Koji Sasaki, Jorge Cortes, Guillermo Garcia-Manero, Tapan Kadia, Farhad Ravandi, Sherry Pierce and Hagop Kantarjian

    Version of Record online : 16 JAN 2015, DOI: 10.1002/ajh.23901

  3. You have full text access to this Open Access content
    Phase I study of anti-CD22 immunoconjugate inotuzumab ozogamicin plus rituximab in relapsed/refractory B-cell non-Hodgkin lymphoma

    Cancer Science

    Volume 103, Issue 5, May 2012, Pages: 933–938, Michinori Ogura, Kiyohiko Hatake, Kiyoshi Ando, Kensei Tobinai, Kota Tokushige, Chiho Ono, Taro Ishibashi and Erik Vandendries

    Version of Record online : 20 MAR 2012, DOI: 10.1111/j.1349-7006.2012.02241.x

  4. You have full text access to this Open Access content
    Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy

    Cancer Science

    Volume 101, Issue 8, August 2010, Pages: 1840–1845, Michinori Ogura, Kensei Tobinai, Kiyohiko Hatake, Toshiki Uchida, Masanobu Kasai, Takashi Oyama, Tatsuya Suzuki, Yukio Kobayashi, Takashi Watanabe, Teruhisa Azuma, Masakazu Mori, Yasuhito Terui, Masahiro Yokoyama, Yuko Mishima, Shunji Takahashi, Chiho Ono and Junko Ohata

    Version of Record online : 23 APR 2010, DOI: 10.1111/j.1349-7006.2010.01601.x

  5. You have free access to this content
    New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia

    Cancer

    Volume 121, Issue 15, August 1, 2015, Pages: 2517–2528, Elias Jabbour, Susan O'Brien, Marina Konopleva and Hagop Kantarjian

    Version of Record online : 17 APR 2015, DOI: 10.1002/cncr.29383

  6. Differential impact of minimal residual disease negativity according to the salvage status in patients with relapsed/refractory B-cell acute lymphoblastic leukemia

    Cancer

    Volume 123, Issue 2, January 1, 2017, Pages: 294–302, Elias Jabbour, Nicholas J. Short, Jeffrey L. Jorgensen, Musa Yilmaz, Farhad Ravandi, Sa A. Wang, Deborah A. Thomas, Joseph Khoury, Richard E. Champlin, Issa Khouri, Partow Kebriaei, Susan M. O'Brien, Guillermo Garcia-Manero, Jorge E. Cortes, Koji Sasaki, Courtney D. Dinardo, Tapan M. Kadia, Nitin Jain, Marina Konopleva, Rebecca Garris and Hagop M. Kantarjian

    Version of Record online : 7 SEP 2016, DOI: 10.1002/cncr.30264

  7. You have free access to this content
    Current status of antibody therapy in ALL

    British Journal of Haematology

    Volume 168, Issue 4, February 2015, Pages: 471–480, Jing Ai and Anjali Advani

    Version of Record online : 10 NOV 2014, DOI: 10.1111/bjh.13205

  8. You have free access to this content
    Antibody-based therapies in B-cell lineage acute lymphoblastic leukaemia

    European Journal of Haematology

    Volume 94, Issue 2, February 2015, Pages: 99–108, Caroline Le Jeune and Xavier Thomas

    Version of Record online : 18 AUG 2014, DOI: 10.1111/ejh.12408

  9. A phase 2 study of inotuzumab ozogamicin in patients with indolent B-cell non-Hodgkin lymphoma refractory to rituximab alone, rituximab and chemotherapy, or radioimmunotherapy

    British Journal of Haematology

    Volume 174, Issue 4, August 2016, Pages: 571–581, Andre Goy, Andres Forero, Nina Wagner-Johnston, W. Christopher Ehmann, Michaela Tsai, Kiyohiko Hatake, Revathi Ananthakrishnan, Angela Volkert, Erik Vandendries and Michinori Ogura

    Version of Record online : 22 APR 2016, DOI: 10.1111/bjh.14094

  10. Calicheamicin Conjugates: Gemtuzumab Ozogamicin (Mylotarg), Inotuzumab Ozogamicin

    Handbook of Therapeutic Antibodies

    Matthias Peipp, Martin Gramatzki, Pages: 1545–1564, 2014

    Published Online : 12 AUG 2014, DOI: 10.1002/9783527682423.ch55

  11. Calicheamicin Antibody-Drug Conjugates and Beyond

    Drug Delivery in Oncology: From Basic Research to Cancer Therapy

    Puja Sapra, John Dijoseph, Hans-Peter Gerber, Pages: 395–410, 2011

    Published Online : 16 DEC 2011, DOI: 10.1002/9783527634057.ch14

  12. Initial experience with CMC-544 (inotuzumab ozogamicin) in pediatric patients with relapsed B-cell acute lymphoblastic leukemia

    Pediatric Blood & Cancer

    Volume 61, Issue 2, February 2014, Pages: 369–372, Michael Rytting, Lisa Triche, Deborah Thomas, Susan O'Brien and Hagop Kantarjian

    Version of Record online : 2 SEP 2013, DOI: 10.1002/pbc.24721

  13. Antibody-Mediated Drug Delivery System for Lymphatic Targeting Treatment

    Antibody-Mediated Drug Delivery Systems: Concepts, Technology, and Applications

    Fang Wu, Hong Ding, Zhirong Zhang, Pages: 169–190, 2012

    Published Online : 23 APR 2012, DOI: 10.1002/9781118229019.ch9

  14. Targeted Therapy for Acute Lymphoblastic Leukemia

    Targeted Therapy in Translational Cancer Research

    Nitin Jain, Susan O'Brien,, Ravandi-Kashani Farhad, Pages: 121–129, 2015

    Published Online : 30 OCT 2015, DOI: 10.1002/9781118468678.ch12

  15. You have free access to this content
    CMC-544 (inotuzumab ozogamicin) shows less effect on multidrug resistant cells: analyses in cell lines and cells from patients with B-cell chronic lymphocytic leukaemia and lymphoma

    British Journal of Haematology

    Volume 146, Issue 1, July 2009, Pages: 34–43, Akihiro Takeshita, Kaori Shinjo, Nozomi Yamakage, Takaaki Ono, Isao Hirano, Hirotaka Matsui, Kazuyuki Shigeno, Satoki Nakamura, Tadasu Tobita, Masato Maekawa, Kazunori Ohnishi, Yoshikazu Sugimoto, Hitoshi Kiyoi, Tomoki Naoe and Ryuzo Ohno

    Version of Record online : 20 APR 2009, DOI: 10.1111/j.1365-2141.2009.07701.x

  16. Antibody-Drug Conjugates for the Treatment of Cancer

    Chemical Biology & Drug Design

    Volume 81, Issue 1, January 2013, Pages: 113–121, John A. Flygare, Thomas H. Pillow and Paul Aristoff

    Version of Record online : 17 DEC 2012, DOI: 10.1111/cbdd.12085

  17. You have free access to this content
    Antibody-Drug Conjugates: A Clinical Pharmacy Perspective on an Emerging Cancer Therapy

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 36, Issue 1, January 2016, Pages: 99–116, Taleen V. Jerjian, Ashley E. Glode, Lisa A. Thompson and Cindy L. O'Bryant

    Version of Record online : 21 JAN 2016, DOI: 10.1002/phar.1687

  18. You have free access to this content
    SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemia

    British Journal of Haematology

    Volume 165, Issue 4, May 2014, Pages: 504–509, Anjali S. Advani, Shannon McDonough, Steven Coutre, Brent Wood, Jerald Radich, Martha Mims, Margaret O'Donnell, Stephanie Elkins, Michael Becker, Megan Othus and Frederick R. Appelbaum

    Version of Record online : 3 MAR 2014, DOI: 10.1111/bjh.12778

  19. Empowered Antibodies for Cancer Therapy

    Drug Delivery in Oncology: From Basic Research to Cancer Therapy

    Stephen C. Alley, Simone Jeger, Robert P. Lyon, Django Sussman, Peter D. Senter, Pages: 289–323, 2011

    Published Online : 16 DEC 2011, DOI: 10.1002/9783527634057.ch10

  20. Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies

    Immunological Reviews

    Volume 263, Issue 1, January 2015, Pages: 68–89, Saar Gill and Carl H. June

    Version of Record online : 15 DEC 2014, DOI: 10.1111/imr.12243